A Study to Obtain Additional Information on the Use of CorMatrix® CanGaroo ECM® Envelope

NCT02418143 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-07-20

No results posted yet for this study

Summary

Actively gather additional information on the use of CorMatrix CanGaroo ECM Envelope in a post market observational study.

Conditions

  • Coronary Disease

Interventions

DEVICE

CorMatrix CanGaroo ECM Envelope

Subjects who have received CorMatrix CanGaroo ECM Envelope for an implantable electronic device placement following a battery change or upgrade.

Sponsors & Collaborators

  • Elutia Inc.

    lead INDUSTRY

Principal Investigators

  • Director, Clinical Development · Aziyo Biologics

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-01-31
Completion
2016-02-29

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02418143 on ClinicalTrials.gov